Wii Aerobic Training in Inhalation-injury Children Post-thermal Burn

Status Recruiting

Clinical Trial Summary

Inhalation injury is a composite of multiple insults including: supra glottic thermal injury, subglottic airway and alveolar poisoning, and systemic poisoning from absorbed small molecule toxins. These contaminant insults independently affect each of the pulmonary functions as well as having a direct effect on systemic physiology. Further, anatomic characteristics can predispose patients to inhalation injury. For example, an infant will develop airway obstructions much faster than an adult due to reduced airway diameter. Understanding the contributions of each of these pathologies to the patient's disease is critical to managing inhalation injury. Wii fit aerobic training gives similar results with traditional rehabilitation practices, it causes less energy costs. This suggests that it can be a suitable rehabilitation tool for adult and elderly people with low energy levels. A review showed that video games are safe and feasible in the children with lung complications. Children' balance, aerobic and cognitive functions, quality of life improved and depressive mood decreased. WII aerobic games also make children to communicate better with other family members.

Clinical Trial Description

This study will investigate the effects of Wii aerobic training in Inhalation-injury Children post-thermal burn. To assign patients to different treatment groups, a table of random numbers generated by a computer was used. Patients were allocated randomly into one of three groups using this method. This study will be carried out at the outpatient clinic of the faculty of physical therapy, modern university for technology and information, Om El masryeen hospital and Embaba general hosbital after referral from dermatologist. Children will perform these exercises in a room supervisor physiotherapist. All parents of children will sign a written consent form after receiving full information about the purpose of the study, procedure, possible benefits, privacy, and use of data. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06326593
Study type	Interventional
Source	MTI University
Contact	Ahmed m El fahl, ph.d
Phone	00201097782441
Email	nn_ee_mm_oo@yahoo.com
Status	Recruiting
Phase	N/A
Start date	February 22, 2024
Completion date	June 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05886543` - Pilates Exercise and Inhalation Injury Post Burn	N/A
Terminated	`NCT01773083` - Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma	Phase 3
Completed	`NCT00997555` - Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients	N/A
Completed	`NCT04125108` - The Effect of a Pulmonary Rehabilitation on Lung Function and Exercise Capacity in Patients With Burn	N/A
Recruiting	`NCT05190497` - Effects of IMT on Pulmonary Functions IN CASES With Inhalation Injury	N/A
Completed	`NCT01194024` - Scoring System for Inhalation Injury
Completed	`NCT04667676` - Respiratory Functions Response To Tens Acupoint Stimulation Post Inhalation Injury	N/A
Recruiting	`NCT05988294` - Pilates Exercises in Patients With Inhalation Injury	N/A
Recruiting	`NCT05915494` - Intermittent-pneumatic Compression in Inhalation-injury Children: Effects on Diaphragm Mobility and Pulmonary Function	N/A
Completed	`NCT05718830` - Selecting Specific Bio-markers and Researching Mechanisms of Immune Regulation From Inhalation Injury and Traumatic Lung Injury Based on Single Cell Sequencing Technology
Not yet recruiting	`NCT01287806` - Ulinastatin in Inhalation Lung Injury	Phase 2
Completed	`NCT05705713` - First-day Computed Tomography: Does it Has a Role in the Assessment of Patients With Inhalation Lung Injury?	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.